|Articles|November 13, 2008

Dr. Zoe Diana Draelos joins Histogen’s scientific advisory board

San Diego - Histogen has announced that Zoe Diana Draelos, M.D., will be joining the company’s scientific advisory board, PR Newswire reports.

San Diego

- Histogen has announced that Zoe Diana Draelos, M.D., will be joining the company’s scientific advisory board, PR Newswire reports.

Dr. Draelos, president of Dermatology Consulting Services, will aid the company in clinical evaluations and product launches in the cosmetic arena.

Histogen is a regenerative medicine company developing products through newborn fibroblasts. Histogen Aesthetics focuses on the development of skin and haircare products for the dermatology, plastic surgery and cosmetics industries.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME